comparemela.com
Home
Live Updates
Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development : comparemela.com
Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development
BEIJING — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced the launch of a new sub-brand, RenBiologics
Related Keywords
United States
,
Ottawa
,
Ontario
,
Canada
,
Beijing
,
China
,
New York
,
Shanghai
,
San Francisco
,
California
,
Connaught
,
Chipscreen Newway Biosciences
,
Barbara Shecter
,
Junshi Biosciences
,
Gabriel Friedman
,
Hansoh Pharma
,
Joe Oconnor
,
Haimen Jiangsu
,
Yuelei Shen
,
Joe Oliver
,
National Post
,
Biocytogen Pharmaceuticals Beijing Co Ltd
,
Merck Kga
,
Canada Revenue Agency
,
Development Business
,
Therapeutic Development
,
Merck Kgaa
,
Business Wire
,
Launches Renbiologics
,
Sub Brand Focused
,
Biocytogen Pharmaceuticals
,
Joeo Connor
,
Victoria Wells
,
Financial Times
,
Financial Post
,
New York Times
,
Eco Development Business
,
Project Integrum
,
Rona Therapeutics
,
Fully Human
,
Platform Licensing Business
,
Canada Governor Tiff Macklem
,
Connaught Building
,
comparemela.com © 2020. All Rights Reserved.